| 000 | 01372 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250510210837.0 | ||
| 264 | 0 | _c19771229 | |
| 008 | 197712s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(77)90786-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoutledge, P A | |
| 245 | 0 | 0 |
_aPredicting patients' warfarin requirements. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 1977 |
||
| 300 |
_a854-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 | _aBlood Coagulation Tests |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Valve Diseases _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMitral Valve |
| 650 | 0 | 4 |
_aThrombophlebitis _xblood |
| 650 | 0 | 4 |
_aThrombosis _xprevention & control |
| 650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
| 700 | 1 | _aDavies, D M | |
| 700 | 1 | _aBell, S M | |
| 700 | 1 | _aCavanagh, J S | |
| 700 | 1 | _aRawlins, M D | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8043 _gp. 854-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(77)90786-3 _zAvailable from publisher's website |
| 999 |
_c70317 _d70317 |
||